UnitedHealth Group reports higher medical loss ratio and earnings challenges in Medicare Advantage, signaling a strategic shift amid rising care costs and regulatory scrutiny.

Optum is creating AI-driven risk coding to improve Medicare patient assessments, coinciding with DOJ investigations into Medicare Advantage practices by UnitedHealth Group.

UnitedHealth Group is reportedly under a DOJ criminal investigation for Medicare fraud, adding to existing probes amid leadership and financial outlook shifts.

Analysis of inflation rebate implementation under the Inflation Reduction Act highlights the need to include Medicare Advantage enrollees to maximize drug cost savings and deter pharmaceutical price hikes.

UnitedHealth Group raises 2025 medical cost projections and appoints Stephen Hemsley as CEO amid rising patient utilization and financial outlook withdrawal.

Insightful analysis of Medicare Advantage Plans highlights comprehensive coverage and positive policyholder experiences following the UHC CEO's death, focusing on insurance market realities and healthcare access.

UnitedHealth Group's unexpected CEO replacement and 2025 guidance withdrawal reflect rising Medicare Advantage costs and market uncertainty, impacting stock performance and investor confidence.

Gavin Galimi, eHealth's General Counsel, leads legal and regulatory strategies supporting Medicare Advantage expansion and digital innovation in health insurance.

UnitedHealth downgraded to Neutral by BofA after suspending 2025 guidance due to Medicare Advantage challenges. Analyst price targets and ratings vary amid uncertainty.

UnitedHealth Group appoints Stephen J. Hemsley as CEO amid 2025 outlook suspension and legal challenges after UnitedHealthcare CEO's shooting.